Ekso Bionics Holdings analyst ratings
Ekso Bionics Holdings analyst ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/29/2022 | 420.23% | HC Wainwright & Co. | $11 → $9 | Maintains | Buy |
| 10/30/2020 | 535.84% | HC Wainwright & Co. | $12 → $11 | Maintains | Buy |
| 08/03/2020 | 420.23% | Aegis Capital | $13 → $9 | Maintains | Buy |
| 06/26/2020 | 593.64% | HC Wainwright & Co. | $8 → $12 | Maintains | Buy |
| 06/15/2020 | 362.43% | HC Wainwright & Co. | $1.2 → $8 | Maintains | Buy |
| 05/21/2020 | 651.45% | Aegis Capital | $15 → $13 | Maintains | Buy |
| 04/13/2020 | 767.05% | Aegis Capital | $21.75 → $15 | Maintains | Buy |
| 03/25/2020 | 362.43% | Cantor Fitzgerald | $1 → $8 | Maintains | Overweight |
| 10/28/2019 | -30.64% | HC Wainwright & Co. | → $1.2 | Initiates Coverage On | → Buy |
| 09/06/2019 | -42.2% | Cantor Fitzgerald | → $1 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析師事務所 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 07/29/2022 | 420.23% | HC Wainwright & Co. | 11 美元 → 9 美元 | 維護 | 購買 |
| 10/30/2020 | 535.84% | HC Wainwright & Co. | 12 美元 → 11 美元 | 維護 | 購買 |
| 08/03/2020 | 420.23% | 宙斯盾資本 | 13 美元 → 9 美元 | 維護 | 購買 |
| 06/26/2020 | 593.64% | HC Wainwright & Co. | 8 美元 → 12 美元 | 維護 | 購買 |
| 06/15/2020 | 362.43% | HC Wainwright & Co. | 1.2 美元 → 8 美元 | 維護 | 購買 |
| 05/21/2020 | 651.45% | 宙斯盾資本 | 15 美元 → 13 美元 | 維護 | 購買 |
| 2020 年 4 月 13 日 | 767.05% | 宙斯盾資本 | 21.75 美元 → 15 美元 | 維護 | 購買 |
| 2020 年 3 月 25 日 | 362.43% | 坎託·菲茨傑拉德 | $1 → 8 美元 | 維護 | 超重 |
| 2019 年 10 月 28 日 | -30.64% | HC Wainwright & Co. | → 1.2 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 09/06/2019 | -42.2% | 坎託·菲茨傑拉德 | → 1 美元 | 啓動覆蓋範圍開啓 | → 超重 |
Ekso Bionics Holdings Questions & Answers
Ekso Bionics Holdings 問答
The latest price target for Ekso Bionics Holdings (NASDAQ: EKSO) was reported by HC Wainwright & Co. on July 29, 2022. The analyst firm set a price target for $9.00 expecting EKSO to rise to within 12 months (a possible 420.23% upside). 1 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2022年7月29日公佈了Ekso Bionics Holdings（納斯達克股票代碼：EKSO）的最新目標股價。該分析公司將目標股價設定爲9.00美元，預計EKSO將在12個月內上漲至9美元（可能上漲420.23％）。去年有1家分析公司公佈了評級。
The latest analyst rating for Ekso Bionics Holdings (NASDAQ: EKSO) was provided by HC Wainwright & Co., and Ekso Bionics Holdings maintained their buy rating.
埃克索仿生控股公司（納斯達克股票代碼：EKSO）的最新分析師評級由HC Wainwright & Co. 提供，Ekso Bionics Holdings維持其買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ekso Bionics Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ekso Bionics Holdings was filed on July 29, 2022 so you should expect the next rating to be made available sometime around July 29, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Ekso Bionics Holdings的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Ekso Bionics Holdings的最後一次評級是在2022年7月29日提交的，因此您應該預計下一個評級將在2023年7月29日左右公佈。
While ratings are subjective and will change, the latest Ekso Bionics Holdings (EKSO) rating was a maintained with a price target of $11.00 to $9.00. The current price Ekso Bionics Holdings (EKSO) is trading at is $1.73, which is out of the analyst's predicted range.
儘管評級是主觀的，並將發生變化，但埃克索仿生控股公司（EKSO）的最新評級維持不變，目標股價爲11.00美元至9.00美元。Ekso Bionics Holdings（EKSO）目前的交易價格爲1.73美元，超出了分析師的預測區間。